Informazioni sui membri
Dr Christophe ORSSAUD
Sostituire
Francia
Gruppi di lavoro: Neuro-oftalmologia Malattie rare (WG2), Vita quotidiana e gruppi di pazienti ipovedenti (TWG5), Diagnostica genetica (TWG6), Registri ed epidemiologia (TWG7), Ricerca (TWG8), Integrazione nazionale (TWG9)
Team
Centro HCP
Il Centro di Riferimento per le Malattie Rare in Oftalmologia è stato riconosciuto nel 2006 come parte del Piano per le Malattie Rare 2006-2011, rietichettato nel 2017....
contatti
OPHTARA – Hôpital Européen Georges Pompidou, Paris, France
Service d'ophtalmologieBât. Lecourbe - RC149 rue de Sèvres
75 015 Paris
France
Test clinici
2020-004594-43 Completato
A phase II, open-label, efficacy study of daily administration of sodium valproate in patients clinically affected by Wolfram syndrome due to monogenic mutation.
interventistica
NCT04561466 Reclutamento, attivo
Study of the efficacy of Befizal® 200mg in the treatment of Leber’s hereditary optic neuropathy
interventistica
NCT00422721 Completato
Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy.
interventistica
NCT02771379 Completato
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber’s Hereditary Optic Neuropathy (LHON).
osservazionale
2017-001215-37 Completato
A pivotal, international, randomised, double-blind, efficacy and safety trial of sodium valporate in paediatric and adult patients with Wolfram Syndrome
interventistica